Rare Earths Boost Heavy Ion Therapy: Joint Research Advances Cancer Treatment

--Symposium on Rare Earth Materials for Enhanced Heavy Ion Radioimmunotherapy Applications Held at Our Hospital

On August 22, the "Symposium on Rare Earth Materials-Enhanced Heavy Ion Radioimmunotherapy Applications," jointly organized by the Institute of Modern Physics of the Chinese Academy of Sciences, the Fujian Institute of Research on the Structure of Matter of the Chinese Academy of Sciences, the Suzhou Institute of Biomedical Engineering and Technology of the Chinese Academy of Sciences, and Wuwei Cancer Hospital in Gansu Province, was successfully held in Wuwei. The conference brought together leading experts from both research and clinical fields to explore innovative applications of rare earth materials in cancer treatment.

  At the symposium, Dr. Sun Minxuan, a researcher from the Suzhou Institute of Biomedical Engineering and Technology of the Chinese Academy of Sciences, delivered an in-depth analysis of the developmental trajectory, cutting-edge technologies, and broad medical prospects of rare earth materials—particularly their potential in enhancing the efficacy of heavy ion therapy. Dr. Zhang Yun, a researcher from the Fujian Institute of Research on the Structure of Matter of the Chinese Academy of Sciences, explored the scientific mechanisms of heavy ion tumor therapy, drawing insights from the latest breakthroughs in stem cell treatment technologies.

Dr. Sun Minxuan from SIOM/CAS delivered a lecture.

Dr. Zhang Yun from FJIRSM/CAS delivered a lecture.

Dean Ye Yancheng of our hospital delivered a presentation titled "The Construction and Clinical Practice of Wuwei Heavy Ion Therapy Center", showcasing our hospital's outstanding achievements and leading position in heavy ion therapy. Our hospital has not only attained remarkable clinical outcomes but also actively embraced technological innovation to continuously advance treatment techniques.

Dean Ye Yancheng lectured on "Wuwei Heavy Ion Therapy Center: Construction & Clinical Practice.

The Wuwei Heavy Ion Therapy Center, as China's first clinical application center for heavy ion therapy systems, has treated 1,437 patients, achieving favorable therapeutic outcomes for complex lesions in the brain, pancreas, lungs and other critical areas, with patients coming from across the country. Meanwhile, it has established a comprehensive, full-life-cycle health management system characterized by integrated tumor therapy, dietary management, psychosomatic health care, traditional Chinese medicine syndrome differentiation, rehabilitation therapy, biological immunocellular therapy, pastoral therapy and cultural therapy.

Wuwei Heavy Ion Center Main Building

Wuwei Heavy Ion Ring Hall

   The participating parties reached a consensus to deepen cooperation in treating refractory diseases such as glioblastoma and lung cancer with heavy ion therapy, jointly exploring new approaches for rare earth materials to enhance the efficacy of heavy ion treatment. Meanwhile, both sides will collaborate to establish a Joint Laboratory for Rare Earth Biomedicine, laying a solid foundation for in-depth scientific research. Looking back eight years, Wuwei Academy of Medical and Science Cancer Hospital took the lead in strategically positioning itself in the fields of genetic diagnosis and cellular therapy. The establishment of the Gansu Branch of the National Engineering Research Center for Beijing Biochip Technology and the Biological Immunocellular Laboratory marked the hospital's advancement toward cutting-edge international technologies for tumor diagnosis and treatment. Today, these platforms have become crucial pillars of precision medicine, working synergistically with heavy ion therapy to form a robust defense against cancer.

Glimpses of the Genetic Biochip Laboratory and Biological Immunocellular Therapy Laboratory​

The successful convening of this symposium has not only deepened the integrated understanding of rare earth materials and heavy ion therapy technologies, but also laid a solid foundation for future in-depth collaboration between the parties. The close integration of scientific research and clinical practice will drive continuous innovation and advancement in heavy ion therapy technology, bringing more hope and therapeutic benefits to cancer patients.